HekaBio LinkedIn

About Us

Color logo - no background.png

HekaBio is a unique platform for healthcare innovation in Japan,
created by a diverse group of multicultural experts

We invest in leading global innovations in oncology, radiation and cardiovascular therapy, and successfully accelerate commercialization


Our mission is to bring significant benefit to patients suffering from intractable diseases


HekaBio K.K.

Head Office

1-9-15 Nihonbashimuromachi, Chuo-ku, Tokyo 103-0022


November 14, 2016


Robert E. Claar


Credit of photo:Louvre Museum,

CC BY-SA 2.0 FR,

via Wikimedia Commons

Meaning of "Heka"

In Egyptian mythology, Heka is the personification of healing and magic. Heka literally means “engaging the spirit or vital force”.

Credit of photo: Esna_Tempel_13.jpg:

Olaf Tausch derivative work: Oltau, CC BY 3.0, via Wikimedia Commons 


Meet The Team


Rob Claar

Co-founder, CEO

Rob creates new businesses that address the unmet needs of patients, doctors, innovators and authorities. He is passionate about developing creative solutions for access to Japan’s healthcare market.


Over three decades, Rob has founded, managed and exited a number of businesses including Junicon, a global healthcare marketing research consultancy, and Vorpal Technologies, a MedTech regulatory consultancy.


He maintains a worldwide trust network with leading innovators in MedTech and pharma through optimism, tenacious follow-through and a spirit of collaboration. 

Ben Pratt

Ben Pratt

Co-founder, COO

Ben has two decades of experience in healthcare strategy development, marketing, and operations. He commercialized and marketed best-in-class medical products globally and in Japan while at Edwards Lifesciences.


As GM at Vorpal Technologies, he consulted for global healthcare innovators and launched Vorpal Women’s Health, a commercial entity sold in 2017.


His forte and personal mission is creating new businesses for the betterment of patient care. Ben holds an MBA from the University of Southern California.

torii_for web_0H6A8402.JPG

Hitoshi Torii


Hitoshi has 30 years of leadership experience in the life science industry including both large and venture biotech and pharmaceutical companies in executive management, finance, business development, and commercial roles.

Hitoshi’s background as a research scientist and financial professional make him a hands-on manager in biotech startups.


He is experienced in private equity fundraising and IPO preparation and holds MBA & USCPA qualifications.


Anne Bille, MD, PhD, MPH

Medical Advisor

Anne is the former head of Medical Affairs, Clinical Development and Operations at Baxalta and Baxter Japan and was Medical Director for programs at Wyeth Japan and Eli Lilly Japan.  Anne is a licenced Psychiatrist and has a track record of leading successful regulatory and clinical programs in oncology, CNS, hemophilia and anesthesia.  Anne has been a resident of Japan for 19 years.

Our Core Values


We maintain internal and external relationships built on common goals,

mutual respect, open communication, trust and teamwork



We approach situations with a positive attitude, acting on needs and

opportunities to deliver inspired solutions


We are proactive self-starters who are accountable for results